ICH Guide Aims To Facilitate Pediatric Trials And Reduce Animal Testing
Offers Harmonized Approach On Juvenile Animal Studies
A new international guideline on non-clinical safety testing in support of pediatric drug development aims to cut unnecessary use of animals.
You may also be interested in...
Europe’s research-based pharmaceutical industry has suggested changes to the draft ICH S11 guideline on nonclinical safety studies for supporting pediatric development programs.
Experts at the International Council for Harmonisation have nearly completed the first draft of a guideline that explains in which situations nonclinical juvenile animal testing is considered informative and necessary to support pediatric drug development. The guideline is expected to address the "discordant advice" that different regulatory agencies currently offer companies in relation to such studies.
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.